IDI [IDI] 8-K: FORM 8-K CURRENT REPORT Date of Report (Date

[FORM 8-K CURRENT REPORT Date of Report (Date of Earliest Event Reported): June 1, 2016 IDI, Inc. Delaware 333-158336 77-0688094 _____________________ _____________ ______________ of incorporation) Identification No.) 2650 North Military Trail, Suite 300, Boca Raton, Florida 33431 _________________________________ ___________ 561-757-4000 Not Applicable Top of the Form Item 5.07. Submission of Matters to a Vote of Security Holders. On June 1,]

By | 2016-06-07T02:35:47+00:00 June 6th, 2016|Categories: Chinese Stocks, IDI, Webplus ver|Tags: , , , , , |0 Comments
Read More

CBPO [China Biologic Products] 8-K: (Original Filing)

[Execution Version CHINA BIOLOGIC PRODUCTS, INC. 2,775,000 SHARES OF COMMON STOCK (PAR VALUE $0.0001 PER SHARE) UNDERWRITING AGREEMENT June 2, 2016 June 2, 2016 Morgan Stanley & Co. International plc 25 Cabot Square, Canary Wharf London, E14 4QA United Kingdom Schedule I As the Sole Underwriter named in Ladies and Gentlemen: Selling Stockholders Company Schedule II Schedule I Underwriter Shares] [June 6, 2016 China Biologic Products, Inc. Re: Registration Statement on Form S-3 Ladies and Gentlemen: Registration Statement Company Commission Act We have examined the registration statement on Form S-3 (No. 333-204761) (the “ Common Stock Preferred Stock Prospectus Prospectus Supplement Shares Selling Stockholders Underwriting Agreement We understand that 2,775,000 shares of Common Stock (the “ As legal counsel to] [China Biologic Announces Secondary Offering of Common Stock BEIJING, China – June 2, 2016 The shares to be sold in this offering represent approximately 10.4 percent of the Company’s current outstanding shares of common stock. Morgan Stanley & Co. International plc is acting as the sole underwriter for the offering. prospectus@morganstanley.com This press release shall not constitute an offer to] []

By | 2016-06-07T02:54:50+00:00 June 6th, 2016|Categories: CBPO, Chinese Stocks, SEC Original|Tags: , , , , , |0 Comments
Read More

CBPO [China Biologic Products] 8-K: Execution Version CHINA BIOLOGIC PRODUCTS, INC. 2,775,000 SHARES

[Execution Version CHINA BIOLOGIC PRODUCTS, INC. 2,775,000 SHARES OF COMMON STOCK (PAR VALUE $0.0001 PER SHARE) UNDERWRITING AGREEMENT June 2, 2016 June 2, 2016 Morgan Stanley & Co. International plc 25 Cabot Square, Canary Wharf London, E14 4QA United Kingdom Schedule I As the Sole Underwriter named in Ladies and Gentlemen: Selling Stockholders Company Schedule II Schedule I Underwriter Shares] [June 6, 2016 China Biologic Products, Inc. Re: Registration Statement on Form S-3 Ladies and Gentlemen: Registration Statement Company Commission Act We have examined the registration statement on Form S-3 (No. 333-204761) (the “ Common Stock Preferred Stock Prospectus Prospectus Supplement Shares Selling Stockholders Underwriting Agreement We understand that 2,775,000 shares of Common Stock (the “ As legal counsel to] [China Biologic Announces Secondary Offering of Common Stock BEIJING, China – June 2, 2016 The shares to be sold in this offering represent approximately 10.4 percent of the Company’s current outstanding shares of common stock. Morgan Stanley & Co. International plc is acting as the sole underwriter for the offering. prospectus@morganstanley.com This press release shall not constitute an offer to] []

By | 2016-06-07T02:55:55+00:00 June 6th, 2016|Categories: CBPO, Chinese Stocks, Webplus ver|Tags: , , , , , |0 Comments
Read More

CCCR [China Commercial Credit] 8-K: (Original Filing)

[STOCK PURCHASE AGREEMENT THIS STOCK PURCHASE AGREEMENT W I T N E S S E T H WHEREAS WHEREAS NOW THEREFORE Definitions 1. 1933 Act “ “ Affiliate “ Business Day “ Closing Date “ Company Plan “ Company’s Knowledge “ Confidential Information “ Control “ Governmental Entity “ Intellectual Property “ Lock-up Period “ Material Adverse Effect “ Material] []

By | 2016-06-03T13:23:05+00:00 June 2nd, 2016|Categories: CCCR, Chinese Stocks, SEC Original|Tags: , , , , , |0 Comments
Read More

CCCR [China Commercial Credit] 8-K: STOCK PURCHASE AGREEMENT THIS STOCK PURCHASE AGREEMENT W

[STOCK PURCHASE AGREEMENT THIS STOCK PURCHASE AGREEMENT W I T N E S S E T H WHEREAS WHEREAS NOW THEREFORE Definitions 1. 1933 Act “ “ Affiliate “ Business Day “ Closing Date “ Company Plan “ Company’s Knowledge “ Confidential Information “ Control “ Governmental Entity “ Intellectual Property “ Lock-up Period “ Material Adverse Effect “ Material] []

By | 2016-06-03T13:23:52+00:00 June 2nd, 2016|Categories: CCCR, Chinese Stocks, Webplus ver|Tags: , , , , , |0 Comments
Read More

IDI [IDI] 8-K: (Original Filing)

[May 23, 2016 IDI, Inc. Re: Common Stock registered under Registration Statement on Form S-3 Ladies and Gentlemen: We have acted as counsel to IDI, Inc., a Delaware corporation (the “Company”), in connection with the Securities Purchase Agreement dated May 17, 2016 (the “Agreement”) by and between the Company and Chardan Capital Markets, LLC, and the investors signatories thereto (the] [FORM 8-K CURRENT REPORT Date of Report (Date of Earliest Event Reported): May 23, 2016 IDI, Inc. Delaware 333-158336 77-0688094 _____________________ _____________ ______________ of incorporation) Identification No.) 2650 North Military Trail, Suite 300, Boca Raton, Florida 33431 _________________________________ ___________ 561-757-4000 Not Applicable Top of the Form Item 8.01 Other Events. Top of the Form]

By | 2016-05-24T04:07:53+00:00 May 23rd, 2016|Categories: Chinese Stocks, IDI, SEC Original|Tags: , , , , , |0 Comments
Read More
Skip to toolbar